Esperion Therapeutics
ESPR
#6820
Rank
A$0.67 B
Marketcap
$3.46
Share price
8.06%
Change (1 day)
141.63%
Change (1 year)

Esperion Therapeutics (ESPR) - Net assets

Net assets on the balance sheet as of June 2024 : -A$0.53 Billion

According to Esperion Therapeutics's latest financial reports the company has -A$0.53 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Esperion Therapeutics - Net assets on balance sheet (from 2001 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$-A$0.67 Billion40.36%
2022-12-31$-A$0.48 Billion75.15%
2021-12-31$-A$0.28 Billion117.28%
2020-12-31$-A$0.13 Billion-538.77%
2019-12-31$A$28.49 M-74.63%
2018-12-31$A$0.11 B-64.17%
2017-12-31$A$0.31 B-1.17%
2016-12-31$A$0.31 B-19.57%
2015-12-31$A$0.39 B141.63%
2014-12-31$A$0.16 B96.46%
2013-12-31$A$83.06 M-596.38%
2012-12-31$-A$16.74 Million183.28%
2011-12-31$-A$5.91 Million
2002-12-31$A$68.76 M-47.22%
2001-12-31$A$0.13 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
A$0.65 B-225.62%๐Ÿ‡บ๐Ÿ‡ธ USA
A$8.20 B-1,672.66%๐Ÿ‡บ๐Ÿ‡ธ USA
A$140.33 B-26,989.20%๐Ÿ‡บ๐Ÿ‡ธ USA
A$44.46 B-8,619.52%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.27 B-151.95%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.36 B-169.72%๐Ÿ‡บ๐Ÿ‡ธ USA